Skip to main content

Scientists managed to “cut out” HIV virus from rats

hiv cure dna double helix
Image used with permission by copyright holder

Science has brought us yet another step closer to an HIV cure with a pair of molecular scissors. A group of researchers at the Lewis Katz School of Medicine at Temple University have managed to “cut out” HIV-1 genes from mice and rat genomes.

“In a proof-of-concept study, we show that our gene editing technology can be effectively delivered to many organs of two small animal models and excise large fragments of viral DNA from the host cell genome,” said Professor Kamel Khalili, who led the study. This, scientists hope, could one day lead to the elimination of the deadly virus in human patients as well.

Recommended Videos

Currently, HIV treatment is contingent upon a cocktail of antiretrovirals, and while these drugs can prevent the virus from replicating, it doesn’t serve as a real cure. Moreover, Temple University points out, “When antiretroviral therapy is interrupted, HIV replication rebounds, placing patients at risk for developing acquired immune deficiency syndrome, or AIDS.” But if doctors are able to fully remove the virus from human genomes altogether, a wholesale solution may finally be in sight.

In conducting their experiment, researchers first infected rats with HIV DNA, then engineered an ex vivo experiment to “cleave the integrated HIV-1 DNA in the host cell genome.” This would potentially excise the viral DNA fragment from the genome altogether. After two weeks, the Temple University team examined their subjects’ DNA, and found that the HIV DNA was no longer present, seemingly removed from every tissue, including the brain, heart, kidney, liver, lungs, spleen, and blood cells.

“The ability of the rAAV delivery system to enter many organs containing the HIV-1 genome and edit the viral DNA is an important indication that this strategy can also overcome viral reactivation from latently infected cells and potentially serve as a curative approach for patients with HIV,” said Dr. Khalili.

The next step for Khalili’s team will be to conduct a larger study on animals, but the team hopes that a clinical trial for human patients could come to fruition within the next several years.

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Waymo, Nexar present AI-based study to protect ‘vulnerable’ road users
waymo data vulnerable road users ml still  1 ea18c3

Robotaxi operator Waymo says its partnership with Nexar, a machine-learning tech firm dedicated to improving road safety, has yielded the largest dataset of its kind in the U.S., which will help inform the driving of its own automated vehicles.

As part of its latest research with Nexar, Waymo has reconstructed hundreds of crashes involving what it calls ‘vulnerable road users’ (VRUs), such as pedestrians walking through crosswalks, biyclists in city streets, or high-speed motorcycle riders on highways.

Read more
Rivian, VW venture kicks off next-gen platform for R1, Scout EVs
Rivian R2, R3, and R3X

The big challenge for Rivian, the EV maker known for its innovative electric and software systems, has long been how to reach the next stage of growth.

That stage came within reach in June, when the California-based company and Volkswagen announced a joint venture involving a $5 billion injection from the German automaker.

Read more
Hyundai teases Ioniq 9 electric SUV’s interior ahead of expected launch
hyundai ioniq 9 teaser launch 63892 image1hyundaimotorpresentsfirstlookationiq9embarkingonaneweraofspaciousevdesign

The Ioniq 9, the much anticipated three-row, electric SUV from Hyundai, will be officially unveiled at the Los Angeles Auto Show next week.

Selected by Newsweek as one of America’s most anticipated new vehicles of 2025, the Ioniq 9 recently had its name changed from the Ioniq 7, which would have numerically followed the popular Ioniq 6, to signal the SUV as Hyundai’s new flagship EV model.

Read more